Philips ePatch and AI analytics platform rolled out to 14 hospitals across Spain to monitor heart patients

Philips Foundation 2023 Annual Report: unlocking quality medical services for over 28 million people in underserved communities

Amplexd Therapeutics, Innovating to Revolutionize the Future of Non-Invasive HPV-induced Cervical Intraepithelial Neoplasia (CIN) Treatments for the Prevention of Cervical Cancer: Developed by Women for Women

[img]http://phpstack-1214942-4313335.cloudwaysapps.com/api/ImageRender/DownloadFile?resourceId=f83bbfc7-6e0b-45d2-9685-2

Philips announces exchange ratio for 2023 dividend

Philips shareholders approve all proposals at the AGM 2024

Philips delivers first-quarter results in line with 2024 performance improvement plan; Resolves the Respironics personal injury and medical monitoring litigation in the US for USD 1.1 billion

Philips Respironics reaches agreement with US government on a consent decree creating a clear path forward

Philips convenes the Annual General Meeting of Shareholders 2024

Leading in health technology innovation: Philips one of the top patent applicants at European Patent Office

Philips and AWS collaborate to scale digital pathology in the cloud, enhancing diagnostic capabilities and improving productivity

Bringing confident diagnosis to more patients at low cost: Philips launches new AI-enabled CT 5300 at #ECR2024

Philips extends leadership in virtually helium-free MRI with more than 1,000 systems installed, expanding patient access worldwide